All blog posts
Total 40 results for
Showing 12 out of 40 results
23 December 2024
Le Patourel v BT - First competition class action to go to trial fails: key takeaways and implications for the regime
01 November 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
14 October 2024
Highlights from the GCR Live: Competition Litigation conference
07 October 2024
General Court largely rejects Qualcomm's challenge to Commission's predatory pricing decision
04 July 2024
Insights from the latest "pay-for-delay" CJEU judgments: fines on Servier and generics drug manufacturers largely upheld (but not over yet)
21 December 2023
Clarity: Over the Hills and (F)Far Away? The FIFA Football Agents Regulations and their interplay with competition law
06 December 2023
Competition law and biosimilars: Time for a new approach or not yet?
15 August 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
15 June 2023
Overview of EU and South African regulatory and competition law in the Pharma sector
14 April 2023
European Commission announces plans for new Article 102 TFEU Guidelines and amends 2008 Guidance on enforcement priorities
24 March 2023
Non-notifiable M&A deals can be reviewed under abuse of dominance rules: does heightened regulatory intervention in deal-making lie ahead?
23 November 2022
SANCTION IMPOSED BY THE SPANISH COMPETITION AUTHORITY ON A PHARMA COMPANY FOR MISUSING LITIGATION STRATEGIES REGARDING PATENTS
Showing 12 out of 40 results
View more